Health nutrients and imaging are evolving to protect women against age-related disorders, finds Frost & Sullivan
Market opportunities in the women’s healthcare imaging and nutrition segment are ripe, especially in developing nations where awareness of preventive medicine is rising. Issues afflicting women include breast cancer, urinary tract infections, anemia, cardiovascular diseases and osteoporosis, a bone-related disorder. In response, the healthcare industry is progressively employing early diagnosis through screening and prescribing preventive solutions in the form of nutrients supplemented through diet.
Analysis from Frost & Sullivan, Technology Trends in Women’s Health (http://www.frost.com/d67b), explores developments in the fields of health nutrients and health imaging for women. Manufacturers are trying to customize nutrients according to a woman’s lifecycle since the needs of prenatal, postnatal and menopausal women are different. The main health nutrients women consume are calcium, iron and vitamin D.
In imaging, technological advancements will focus on platforms that:
- Reduce the ionizing radiation dose
- Provides physiological image data to highlight cellular activities indicative of cancer, rather than only using anatomical
- Allows image acquisition and viewing in more than two spatial dimensions
- For complimentary access to more information on this research, please visit: http://bit.ly/1LPCT4Z.
“Customized innovation is essential in the women’s health sector,” said Technical Insights Industry Analyst Darshana De. “In addition to age-related nutritional requirements, a woman’s health needs vary according to geographic and consumer preferences. Demand is high for natural supplements, strong scientific evidence of health claims and minimal side effects. For instance, the constipation and gastrointestinal symptoms caused by available calcium tablets are driving innovations within the industry to provide a more natural form of calcium.”
In the women’s imaging segment, digitization is a sweeping trend. Hospitals and screening centers worldwide are digitizing systems to optimize workflows and enhance image clarity. Government initiatives are pushing several advances. A U.S. federal bill (HR 3102) mandates breast density reporting on a national level to generate interest in newer technologies improving image screening accuracy.
“Tomosynthesis will become the primary screening modality; it offers the ability to view slices of the breast to better differentiate actual lesions from areas of overlapping dense tissue,” noted De.
Similarly, government-initiated screening programs, designed to diagnose osteoporosis in developed countries, are encouraging bone density scans and boosting the sales of densitometry systems. However, the high initial investment for scanning systems and reimbursement issues can bring challenges to the market.
Technology Trends in Women’s Health, a part of the TechVision (http://ww2.frost.com/research/technology/health-wellness) subscription, identifies and profiles 10 technologies expected to shape the medical device and imaging industry. The list includes technologies that are already in the market as well as recently commercialized technologies. This research throws light on technology capability, maturity, global research intensity, adoption over the short and medium terms, and funding activities.
Frost & Sullivan’s global TechVision practice is focused on innovation, disruption and convergence that provides a variety of technology based alerts, newsletters and research services as well as growth consulting services. Its premier offering, the TechVision program, identifies and evaluates the most valuable emerging and disruptive technologies enabling products with near-term potential. A unique feature of the TechVision program is an annual selection of 50 technologies that can generate convergence scenarios, possibly disrupt the innovation landscape, and drive transformational growth. View a summary of our TechVision program by clicking on the following link: http://ifrost.frost.com/TechVision_Demo.